Hua Medicine (Shanghai) Ltd. (2552.HK)
HKD 1.46
(0.69%)
HKD 1.46
(0.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 76.61 Million | 17.59 Million | - | 8.66 Million | 22.25 Million | 9.12 Million |
| Cost of Revenue | 39.23 Million | 9.91 Million | - | - | - | - |
| Gross Profit | 37.37 Million | 7.68 Million | - | 8.66 Million | 22.25 Million | 9.12 Million |
| Operating Expenses | 37.37 Million | 248.36 Million | 315.18 Million | 352.38 Million | 446.23 Million | 399.25 Million |
| Selling, General and Administrative Expenses | 203.9 Million | 145.27 Million | 134.83 Million | 140.08 Million | 146.58 Million | 139.31 Million |
| Research and Development Expenses | 171.53 Million | 129.52 Million | 186.83 Million | 220.96 Million | 321.9 Million | 269.06 Million |
| Other Expenses | - | -26.44 Million | -6.49 Million | -8.66 Million | -22.25 Million | -3.26 Billion |
| Cost and Expenses | 365.7 Million | 258.27 Million | 315.18 Million | 352.38 Million | 446.23 Million | 399.25 Million |
| Operating Income | -289.09 Million | -199.58 Million | -320.51 Million | -389.83 Million | -422.63 Million | -399.25 Million |
| Interest Expense | 7.9 Million | 3.66 Million | 3.95 Million | 4.39 Million | 907 Thousand | 3.53 Million |
| Income Tax Expense | - | 259 Thousand | 5.21 Million | 3.29 Million | 2.63 Million | -3.2 Billion |
| Earnings before Tax | -211.23 Million | -203.5 Million | -325.73 Million | -393.13 Million | -425.27 Million | -3.6 Billion |
| Net Income | -211.23 Million | -203.76 Million | -330.95 Million | -396.42 Million | -427.9 Million | -3.6 Billion |
| Earnings Per Share Basic | -0.22 | -0.21 | -0.35 | -0.42 | -0.45 | -10.07 |
| Earnings Per Share Diluted | -0.22 | -0.21 | -0.35 | -0.42 | -0.45 | -10.07 |
| Weighted Average Shares Outstanding | 977.05 Million | 966.73 Million | 957.48 Million | 950.5 Million | 942.06 Million | 357.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 977.05 Million | 966.73 Million | 957.48 Million | 950.5 Million | 942.06 Million | 357.86 Million |
| Gross Margin | 0.49 | 0.44 | - | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -2.18 | -9.53 | - | -42.87 | -18.52 | -394.26 |
| Profit Margin | -2.76 | -11.58 | - | -45.76 | -19.23 | -394.65 |
| EBITDA | -167.08 Million | -168.06 Million | -309.68 Million | -347.43 Million | -442.87 Million | -358.8 Million |
| Earnings Before Tax Margin | -3.77 | -11.34 | - | -45.00 | -18.99 | -43.73 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 51.33 Million | 51.33 Million | 3.13 Million | 76.61 Million | 3.13 Million | 35.16 Million |
| Cost of Revenue | 27.45 Million | 27.45 Million | 6.47 Million | 39.23 Million | 6.47 Million | 13.14 Million |
| Gross Profit | 23.88 Million | 23.88 Million | -3.33 Million | 37.37 Million | -3.33 Million | 22.02 Million |
| Operating Expenses | 120.99 Million | 120.99 Million | 98.75 Million | 326.46 Million | 59.32 Million | 69.27 Million |
| Selling, General and Administrative Expenses | 61.1 Million | 61.1 Million | 48.48 Million | - | 48.48 Million | 53.46 Million |
| Research and Development Expenses | 59.88 Million | 59.88 Million | 50.26 Million | - | 50.26 Million | 35.49 Million |
| Other Expenses | - | - | - | 69.25 Million | - | - |
| Cost and Expenses | 148.44 Million | 148.44 Million | 105.22 Million | 365.7 Million | 65.8 Million | 82.42 Million |
| Operating Income | -97.11 Million | -97.11 Million | -102.08 Million | -338.06 Million | -102.08 Million | -66.94 Million |
| Interest Expense | - | - | - | 7.9 Million | - | 3.99 Million |
| Income Tax Expense | - | - | - | 134.73 Million | - | -1.00 |
| Earnings before Tax | -71.12 Million | -71.12 Million | -60.56 Million | -211.23 Million | -60.56 Million | -45.04 Million |
| Net Income | -71.12 Million | -71.12 Million | -60.56 Million | -211.23 Million | -60.56 Million | -45.04 Million |
| Earnings Per Share Basic | -0.07 | -0.07 | -0.06 | - | -0.06 | -0.05 |
| Earnings Per Share Diluted | -0.07 | -0.07 | -0.06 | - | -0.06 | -0.05 |
| Weighted Average Shares Outstanding | 980.64 Million | 980.64 Million | 980.11 Million | 977.05 Million | 980.11 Million | 974.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 980.64 Million | 980.64 Million | 980.1 Million | 977.05 Million | 980.1 Million | 974 Million |
| Gross Margin | 0.47 | 0.47 | -1.06 | 0.49 | -1.06 | 0.63 |
| EBIT Margin | -1.82 | -1.82 | -31.25 | - | -31.25 | -1.79 |
| Profit Margin | -1.39 | -1.39 | -19.29 | -2.76 | -19.29 | -1.28 |
| EBITDA | -93.34 Million | -93.34 Million | -98.12 Million | - | -98.12 Million | -62.99 Million |
| Earnings Before Tax Margin | -1.89 | -1.89 | -32.52 | -4.41 | -32.52 | -1.90 |
7409
8031
RDWR
VSSSF
HGASW
ETRUF